AP
FMI

AHL Partners’s Foundation Medicine, Inc. FMI Stock Holding History

AHL Partners’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-25,514
Closed -$864K – 859
2015
Q2 		$864K Buy
+25,514
New +$1.03M 0.03% 579

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AHL Partners's FMI Position: Q3 2015 in Review

AHL Partners sold out of Foundation Medicine, Inc. (FMI) in Q3 2015, closing a stake of 25,514 shares — an estimated $864K sold.

AHL Partners first reported a position in FMI in Q2 2015 and held it in 1 quarter. The position peaked at $864K in Q2 2015. 89 funds tracked by Wall St. Rank hold FMI as of Q3 2015.

  • AHL Partners reported no remaining Foundation Medicine, Inc. position as of Q3 2015 after selling out during the quarter.
  • AHL Partners sold 25,514 Foundation Medicine, Inc. shares in Q3 2015, an estimated $864K.
  • AHL Partners first reported a position in Foundation Medicine, Inc. in Q2 2015 and held it in 1 quarter.
  • AHL Partners's Foundation Medicine, Inc. position peaked at $864K in Q2 2015.
  • 89 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2015.

Based on AHL Partners's 13F filing for Q3 2015, filed 16 Nov 2015.